Prolaeis™

Broad-Spectrum Mitigant with Anti-inflammatory properties

A highly refined form of monoglycerides. Prolaeis is another solution to reduce the risk of lipid-membraned viruses like African Swine Fever.

  • Monoglycerides significantly reduce infective loads of lipid-membraned viruses
  • Reduces challenges from gram-positive pathogens like Pneumococci, Staph. and Strep.
  • Reduces inflammation, allowing energy to be used for more productive processes.

As a broad spectrum mitigant, Prolaeis is 20X more potent than medium-chain fatty acids at reducing the load of infective pathogens. Even in a PRRS virus challenge model, the monoglycerides in Prolaeis were effective at eliminating clinical disease and maintaining growth performance compared to the infected control animals. In addition, Prolaeis has anti-inflammatory activity which can prevent the diversion of nutrients to fuel inflammation and toward more productive uses such as growth.

See the newest research here.